Otezla

Bristol Myers Squibb

Pharma

FDA expands label for BMS' Sotyktu to treat psoriatic arthritis

The FDA has expanded the label for BMS' Sotyktu, blessing it as a treatment for psoriatic arthritis on top of its existing nod for plaque psoriasis.

Kevin Dunleavy Mar 9, 2026 11:16am

NBC Saturday Night Live Otezla parody ad

'SNL' pokes fun at mysteries of Amgen's Otezla for psoriasis

Mar 9, 2026 11:05am

advertising ads money megaphone

The top 10 pharma drug ad spenders of 2024

Jun 30, 2025 3:00am

Sotyktu

Trial results enhance BMS bid for Sotyktu in psoriatic arthritis

Mar 10, 2025 8:38am

BMS

Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says

Dec 23, 2024 11:25am

Amgen

Amgen tipped to keep Otezla market share in BMS' Sotyktu fight

Sep 5, 2023 7:25am